ASAP Act

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 6130 Introduced in House (IH)]

<DOC>






119th CONGRESS
  1st Session
                                H. R. 6130

To amend title XVIII of the Social Security Act to provide for Medicare 
           coverage of blood-based dementia screening tests.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           November 19, 2025

Mr. Buchanan (for himself and Mr. Tonko) introduced the following bill; 
  which was referred to the Committee on Energy and Commerce, and in 
    addition to the Committee on Ways and Means, for a period to be 
subsequently determined by the Speaker, in each case for consideration 
  of such provisions as fall within the jurisdiction of the committee 
                               concerned

_______________________________________________________________________

                                 A BILL


 
To amend title XVIII of the Social Security Act to provide for Medicare 
           coverage of blood-based dementia screening tests.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Alzheimer's Screening and Prevention 
Act of 2025'' or the ``ASAP Act''.

SEC. 2. MEDICARE COVERAGE OF ALZHEIMER'S DISEASE AND RELATED DEMENTIAS 
              EARLY DETECTION SCREENING TESTS.

    (a) Coverage.--Section 1861 of the Social Security Act (42 U.S.C. 
1395x) is amended--
            (1) in subsection (s)(2)--
                    (A) in subparagraph (JJ), by striking the semicolon 
                at the end and inserting ``; and''; and
                    (B) by adding at the end the following new 
                subparagraph:
            ``(KK) Alzheimer's disease and related dementias early 
        detection screening tests (as defined in subsection (nnn));''; 
        and
            (2) by adding at the end the following new subsection:
    ``(nnn) Alzheimer's Disease and Related Dementias Early Detection 
Screening Tests.--The term `Alzheimer's disease and related dementias 
early detection screening test' means a test furnished to an individual 
for the detection of the pre-symptomatic and early stage of Alzheimer's 
disease or related dementias on or after January 1, 2028, that--
            ``(1) is cleared under section 510(k), classified under 
        section 513(f)(2), or approved under section 515 of the Federal 
        Food, Drug, and Cosmetic Act; and
            ``(2) is--
                    ``(A) a genomic sequencing blood or blood product 
                test; or
                    ``(B) such other equivalent test, including a 
                single-analyte test, blood test analysis of cell-free 
                nucleic acids, multiplex panel test, whole genome 
                sequencing, protein expression, whole exome, whole 
                transcriptome, and medical imaging (which are based on 
                blood, blood products, tissue, urine or other 
                biospecimen), as the Secretary determines appropriate 
                in providing results comparable to those obtained with 
                a test described in subparagraph (A).''.
    (b) Payment.--Section 1833(h)(1)(A) of the Social Security Act (42 
U.S.C. 1395l(h)(1)(A)) is amended by inserting ``Alzheimer's disease 
and related dementias early detection screening tests under section 
1861(nnn) and'' after ``including''.
                                 <all>